Epidemiological reports have suggested that the consumption of foods rich in flavonoids is associated with a lower incidence of certain degenerative diseases, including cardiovascular disease. Flavanols and their related oligomers, the procyanidins CFP, isolated from cocoa can modulate the production and level of several signaling molecules associated with immune function and inflammation in vitro, including several cytokines and eicosanoids. To further elucidate the potential immuno-modulatory functions of flavanol-rich cocoa, the present investigation examined whether isolated CFP fractions (monomers through decamers) influence the secretion of tumor necrosis factor-a (TNF-a) from resting and phytohemagluttinin (PHA)-stimulated human peripheral blood mononuclear cells (PBMC). We used an in vitro culture system where PBMC from 14 healthy subjects were introduced to individual CFP fractions for 72 h prior to measuring the levels of TNF-a released. The intermediate-sized CFP fractions (tetramers through octamers) were the most active on resting cells, causing a 3-4 fold increase in TNF-a relative to media baseline. The monomers and dimers were the least stimulatory of the fractions tested, displaying a 42 and 31% increase, respectively, over media control, whereas the trimers, nonamers and decamers showed an intermediate stimulation of this cytokine. In the presence of PHA, the intermediate-sized CFP fractions again were the most active, enhancing TNF-a secretion in the range of 48 -128% relative to the PHA control. The monomers and dimers were slightly inhibitory (2 1.5 and 2 15%, respectively), while trimers, nonamers and decamers stimulated moderate increases in TNF-a levels (13, 19 and 15%, respectively). The above results lend support to the concept that CFP can be immunomodulatory. The stimulation of TNF-a secretion may contribute to the putative beneficial effects of dietary flavanoids against microbial infection and tumorigenesis.
INTRODUCTION
Cocoa and its derivative products, such as chocolate, have recently garnered considerable scientific attention, in part because they can be rich in certain flavanoids. In particular, flavanol subclass, including (2 )-epicatechin, (þ )-catechin and their related oligomers, the procyanidins CFP, can be abundant in cocoa and chocolate products ( Fig. 1 ) Lazarus et al., 1999) . The presence of flavonoids in notable concentrations in certain foods (e.g. select fruits, vegetables and legumes) has triggered numerous studies on their potential health benefits, and accumulating epidemiological evidence suggests that consumption of flavonoid-rich foods and beverages are associated with a reduced risk of cardiovascular disease and certain cancers (Rice-Evans et al., 1995; Stoner and Mukhtar, 1995; Holt et al. 2002a; Kris-Etherton and Keen, 2002) . While cocoa contains a complex mixture of CFP, only the monomeric flavanols and small amounts of the procyanidin dimers have been measured in blood following consumption Wang et al., 2000; Baba et al., 2001; Holt et al., 2002b; Steinberg et al., 2002) . Limited information is available concerning the absorption and metabolism of the larger cocoa procyanidins; however, a significant fraction of these procyanidins ($ trimers) appear to reach the upper intestine intact following the consumption of a CFP-enriched meal (Rios et al., 2002) .
Recently, select CFP have demonstrated activity in vivo and in vitro that is suggestive of potential cardiovascular benefits. The focus of this research has generally centered around the concept that CFP-rich foods might improve tissue oxidant defense systems (Rice-Evans et al., 1995; Kris-Etherton and Keen, 2002) , reduce platelet reactivity Holt et al., 2002a; Pearson et al., 2002) and improve vascular health by inducing vascular relaxation (Arteel and Sies, 1999; Stein et al., 1999; Karim et al., 2000; Duffy et al., 2001) . The mechanisms responsible, at least in part, for CFP-induced increases in endothelium-dependent relaxation are thought to involve the modulation of nitric oxide (NO) (Arteel and Sies, 1999; Karim et al., 2000) and select eicosanoid levels (Schramm et al., 2001; Holt et al., 2002a; Schewe et al., 2002) , as well as the augmentation of select arms of the oxidant defense system (Rice-Evans et al., 1995; 1996; Bagchi et al., 1997; Virgili et al., 1998; Arteel and Sies, 1999; Lotito et al., 2000; Wang et al., 2000; Pearson et al., 2001; Kris-Etherton and Keen, 2002; Zhu et al., 2002) .
Complementing the above, we have demonstrated that distinct CFP fractions have the potential to modulate the production of several immunomodulatory cytokines. Under similar in vitro culture settings, select CFPs were shown to effectively suppress the production of cytokines (IL-1b and IL-2) that promote inflammation (Mao et al., 1999; 2000a,b) while increasing the release of antiinflammatory cytokines (IL-4 and IL-5) (Mao et al., 2000c; . Interestingly, CFP had a differential effect on the peripheral blood mononuclear cells (PBMC) production of TGF-b 1 , depending on the constitutive production of the cytokine (Mao et al., 2003) . Tumor growth factor-b 1 can benefit the cardiovascular system by actively maintaining the normal physiological phenotype of endothelial cells and smooth muscle cells in the arterial vessel wall (Grainger, 1997) . However, excess production of TGF-b 1 can cause extracellular matrix accumulation that is unfavorable for injured vessel wall, which can consequently lead to cardiac fibrosis (Lijnen et al., 2000) . We observed that the PBMC isolated from individuals with low baseline levels of TGF-b 1 were stimulated by individual fractions to enhance secretion, whereas production from PBMC isolated from high baseline producers was inhibited by the cocoa procyandins and flavanols (Mao et al., 2003) . The above results suggest that CFP can have differential effects in the production of certain cytokines depending on the immunological status of the individual. In a separate study, we reported that smaller CFPs may contribute to the health of the oral cavity by augmenting the mitogen-induced secretion of IL-5 (Mao et al., 2002) . Interleukin-5, as an integral cytokine, is responsible for mediating the production of IgA, and thus conferring protection against periodontitis (Kinane et al., 1999; Salvi and Holgate, 1999 ). In the current investigation, we wanted to extend our existing knowledge of the immuno-modulatory potential of CFP to their effects on the production of tumor necrosis factoralpha (TNF-a) from human PBMC.
MATERIALS AND METHODS

Cocoa Fraction Preparation
Water soluble CFP fractions were prepared from Cocoaproe cocoa and quantified by LC-MS as detailed by Adamson et al. (1999) , and were provided by Mars, Incorporated (Hackettstown, NJ). The monomers fraction contained the flavan-3-ols, (2 )-epicatechin and (þ ) catechin. Purified oligomers (dimers through decamers) of these monomeric procyanidins were investigated (Fig. 1) . The purified CFP fractions contained less than 0.5% (w/w) of total alkaloids (theobromine and caffeine). The monomer and procyanidin composition, estimated by HPLC and molecular weights of these preparations are shown in Table I . All samples were suspended in RPMI 1640 (Invitrogen Corp., Carlsbad, CA) with 10% heat inactivated fetal bovine serum (Atlanta Biologicals, Norcross, GA). They were then diluted with the same medium to final concentrations of FIGURE 1 Chemical structures of the most common flavan-3-ol monomers and procyanidins (dimers to decamers) in cocoa.
25 mg/ml. We based the concentration of flavonoids used in this study on prior dose response analysis conducted by our laboratory and others assessing the impact of these compounds on cytokine production and release (Sanbongi et al., 1997; Mao et al., 1999; 2000a,b,c; .
PBMC Isolation
Peripheral blood from healthy volunteers was collected into sodium citrate-containing tubes and mixed 1:1 with Hanks' Balanced Salt Solution (HBSS; Invitrogen) without calcium chloride, magnesium chloride or magnesium sulfate. The diluted blood was then layered over a Histopaque w -1077 gradient (Sigma, St Louis, MO) and centrifuged at 500g for 30 min at room temperature. PBMC were harvested from the interface layer, washed twice with HBSS and then counted. The cells were resuspended in RPMI 1640 containing 10% fetal bovine serum and supplemented with 0.1% of a 50 mg/ml gentamicin solution (Invitrogen). PBMC concentration was adjusted to 2 £ 10 6 viable cells/ml after estimation of viability by trypan blue exclusion assay. Viability was consistently greater that 96%.
Culture of PBMC with Cocoa FP Fractions
Five hundred microliters of a 1:0 £ 10 6 cell suspension were cultured with equal volumes of the various CFP treatments at 378C with 5% CO 2 in 48-well plates. Resting PBMC were incubated with individual CFP fractions at 25 mg/ml in the presence or absence of PHA at 25 mg/ml. All treatments were performed in duplicate. Following a 72 h incubation, the supernatant fractions were harvested for ELISA analysis.
TNF-a (ELISA)
Culture supernatant fractions were harvested after 72 h and stored at 2 208C until analysis by ELISA. Ninety-six well Costar EIA plates (Cat. #2592) were coated with mouse anti-TNF-a supplied in the DuoSet Human TNF-a ELISA Development Kit (R and D Systems, Minneapolis, MN). Supernates were measured for TNF-a concentrations according to the manufacturers' recommendations. The lowest TNF-a standard for the ELISA system was 15.6 pg/ml.
Statistics
The effects of different CFP fractions on the secretion of TNF-a were examined in unstimulated resting PBMC. Results were compared by Student paired t-test with a two-tailed p-value (i.e. control cells without CFP vs. cells treated with individual CFP fractions). Significance was taken as p , 0:05:
RESULTS
Unstimulated resting PBMC were prepared and incubated with individual CFP fractions at 25 mg/ml. TNF-a production was then assessed in the supernatant fractions following a 72 h incubation period. ELISA analysis revealed that the CFP were stimulatory for the secretion of TNF-a, regardless of the degree of oligomerization (Fig. 2) . The monomeric and dimeric fractions were the least stimulatory of the group of fractions tested, displaying 42 and 31% increases, respectively, over media baseline level ð315^96 pg=mlÞ (Table II) . The intermediate-sized procyanidins (tetramers through octamers) induced a marked 3 -4 fold increase over media baseline (Table II) . At levels between the two extremes, the trimeric, nonumeric and decameric fractions stimulated the release of TNF-a approximately two fold over baseline control (Table II) .
In the second part of this study, the effects of CFP on the production of TNF-a by stimulated PBMC were investigated. In a similar in vitro culture system, the CFP treated cells, at the same concentration (25 mg/ml) as described above, were co-incubated with PHA at 25 mg/ml for 72 h prior to the harvest of supernates. Phytohemagglutinin, a mitogen known to stimulate CD4 þ T H 1 and CD8 þ T cells, caused a marked increase in TNF-a secretion ð2668^318 pg=mlÞ from PBMC in comparison to unstimulated media control ð315^96 pg=mlÞ: In PHAstimulated PBMC, the CFP fractions displayed similar patterns of response to that observed in the resting cells (Fig. 3) . In particular, the intermediate-sized fractions (tetramers through octamers) were able to significantly enhance the level of TNF-a secretion in the range of 48 -128% over the PHA control (Table II) . Consistent with the CFP effects observed in resting PBMC, the trimeric, nonumeric and decameric fractions induced moderate increases of 13-19% over the PHA control in stimulated cells. In contrast to the higher molecular weight fractions, the monomeric and dimeric cocoa fractions suppressed the PHA-induced response by 1.5 and 15%, respectively. Kris-Etherton and Keen, 2002), as well as the ability to modulate the levels of eicosanoids, NO and peroxynitrite (Arteel and Sies, 1999; Schramm et al., 2001; Schewe et al., 2002) . Complementary to the properties suggested above, we have demonstrated that select CFP fractions can modulate the production of cytokines associated with inflammation (IL-1b, IL-2 and IL-4) (Mao et al., 1999; 2000a,b,c) , vascular health (TGF-b 1 ) (Mao et al., 2003) , and oral cavity health (IL-5) (Mao et al., 2002) . Here, we have extended these findings to evaluate the effect of CFP monomers to decamers on the production of TNF-a.
In the present study, we have shown that the intermediate-sized CFP fractions (tetramers to octamers) can significantly augment the release of TNF-a from unstimulated, and mitogen-induced human PBMC, while the monomeric and dimeric fractions proved to be only moderately stimulatory in resting cells, and slightly inhibitory in the presence of PHA. It has been previously shown that mitogen-stimulated human PBMC displayed optimum TNF-a levels at 24 h, and that the levels steadily decline following this timepoint (Feldman et al., 1999) . Since our measurements were taken at 72 h postexposure, it is possible that the levels observed with our current protocol are significantly diminished. Indeed, the inhibition displayed by the monomeric and dimeric CFP fractions with PHA-stimulated PBMC might be FIGURE 2 The effect of cocoa FP on secretion of TNF-a from unstimulated PBMC. PBMC were incubated with individual cocoa fractions (25 mg/ml) for 72 h before supernates were extracted for ELISA analysis (mean^SEM; n ¼ 10). Values induced from cocoa treatment were compared with control values (i.e. media baseline without cocoa) using a Student paired t-test with a two-tailed p-value. *Significance was taken as p , 0:05:
misleading, as these small fractions might also augment TNF-a secretion during early exposure. Although flavanols, a subgroup of compounds belonging to the flavanoid family, are found in both cocoa and tea, there are significant structural differences, not to mention the catechin content of chocolate can be four times that of tea (Arts et al., 1999) . The predominant catechins found in tea are (2 )-epicatechin gallate and (2 )-epigallocatechin gallate (EGCG), with EGCG accounting for greater than 40% of the total polyphenols (Hara, 1997) . Several groups have reported that EGCG can inhibit TNF-a production at both the transcriptional and protein levels by blocking nuclear transcription factor-kB (NF-kB) in rat and murine models (Yang et al., 1998; Fujiki et al., 1999; Suganuma et al., 2000; Yang et al., 2001) . Interestingly, when EGCG was added to a murine alveolar macrophage cell line (MH-S) pretreated with nicotine, EGCG diminished the nicotine-induced suppression of TNF-a production (Matsunaga et al., 2002) . However, in another study utilizing human leukocytes, EGCG had no effect on the production of TNF-a (Crouvezier et al., 2001) .
TNF-a is a proinflammatory cytokine with numerous biological functions critical for response to infections. A pivotal role of TNF-a is its ability to activate, and subsequently to enhance, the antimicrobial and tumoricidal activities of macrophages. In a previous study, we reported that the pentameric through decameric CFP fractions can be stimulatory for another proinflammatory cytokine, IL-1b, in the presence and absence of PHA (Mao et al., 2000a) . Taken together with our present study, it is evident that under some circumstances, the larger cocoa CFP fractions ($ pentamer) can be proinflammatory, triggering high production of IL-1b and TNF-a relative to controls.
The mechanism(s) by which CFP modulate cytokine production are unclear. However, eicosanoids have been postulated to play a pivotal role in the regulation of TNF-a gene expression (Jongeneel, 1994) . Prostaglandins and leukotrienes are known to have antagonistic effects with the downregulation of TNF-a production attributed to prostaglandins (Jongeneel, 1994) . Inhibition of cyclooxygenase (COX) and lipoxygenase, key enzymes in the biosythesis of prostaglandins and leukotrienes, respectively, will in turn alter TNF-a levels (Jongeneel, 1994) . Recently, it has been shown that (þ )-catechin can inhibit COX activity (Noreen et al., 1998) . Therefore, it is plausible that the TNF-a stimulation observed with our monomeric fraction is, in part, due to the presence of (þ )-catechin interfering with the normal negative feedback loop mediated by prostaglandins (Jongeneel, 1994) . Alternatively, it has recently been shown that CFP, particularly (2 )-epicatechin and the procyanidin dimers, can display significant inhibition of 5-lipoxygenase, whereas the trimeric through pentameric fractions show intermediate suppression, and the larger procyanidins (hexamers through nonamers) are relatively inactive (Schewe et al., 2002) . This observation is consistent with the present analysis in which the monomer and dimer fractions were the least stimulatory when compared with the larger procyanidins.
As alluded to above, there is currently no consensus concerning the effects of flavonoids on the production of FIGURE 3 The effect of cocoa FP on secretion of TNF-a from PHA-stimulated PBMC. PBMC were incubated with individual cocoa fractions (25 mg/ml) in the presence of PHA (25 mg/ml) for 72 h before supernates were extracted for ELISA analysis (mean^SEM; n ¼ 14). Values induced from cocoa treatment were compared with control values (i.e. media baseline without cocoa) using a Student paired t-test with a two-tailed p-value. *Significance was taken as p , 0:05:
TNF-a. In one study, it was shown that monomeric and dimeric procyanidins inhibited TNF-a release from murine RAW 264.7 macrophages, while the trimeric fraction enhanced secretion (Park et al., 2000) . Wine polyphenols also displayed different effects on cytokine production. Whereas quercetin decreased the LPSstimulated release of TNF-a from RAW 264.7 macrophages, resveratrol augmented production (Wadsworth and Koop, 1999) . Clearly, the discrepancy in these in vitro studies lies in the structure of plant polyphenols and their degree of polymerization, as well as the type of cells that are being exposed to these compounds in an in vitro setting. Nevertheless, our analysis suggests that incubation of human PBMC with CFP fractions not only modulates the production of TNF-a, but can significantly upregulate the synthesis and secretion of this proinflammatory cytokine. In summary, this investigation implicates that CFP may provide thearapeutic protection against certain microbial infections and tumorigenesis. Given the bioavailability of the CFP compounds, it can be speculated that the higher oligomers will primarily exert effects in the gastrointestinal tract. The relatively moderate effect of the monomers and dimers on TNF-a production suggests that they would have minimal effects on cardiovascular health with respect to TNF-a pathways.
